Answers are grounded in this paper and cite their sources.
Considering that trastuzumab is being increasingly used and that severe thrombocytopenia is a potentially life-threatening complication, its association must be seriously considered.
No takes yet. Share an insight, caveat, or question.
Miarons et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: